Industry Briefs: November 19, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Allergan has agreed to acquire SkinMedica’s topical aesthetics skin-care business.
bioMérieux and Quanterix have entered into an agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications.
GVK Biosciences has received approvals from the Atomic Energy Regulatory Board and the Indian government, to carry out 3H and 14C synthesis activities.
Jubilant HollisterStier has announced that its contract manufacturing and services division has secured more than $100 million in contracts with leading pharmaceutical companies for the commercial manufacturing of multiple sterile parenteral products.
Pacific BioLabs has acquired Bay Bioanalytical Laboratory, thus adding analytical and bioanalytical chemistry to Pacific BioLabs’ existing in vivo preclinical and microbiological testing services.
Recipharm and Vetcare have entered into an agreement for the development and manufacture of a parenteral veterinary product.
Sensient Pharmaceutical has extended its proprietary line of Microfine natural colors to provide a complete natural color coating system ideal for the nutraceutical market.
Synerlab and AXA Private Equity have announced the acquisitions of Lyofal and IDD-TECH Orleans.
People News
Onyx Scientific has appointed Dan Brisard business development director.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.